Sarepta shares slump after reports of third patient death this year
The patient was enrolled in an early-stage study testing Sarepta's gene therapy to treat a condition called limb-girdle muscular dystrophy, according to a Bloomberg report, which cited a company spokesperson. STAT news reported that the patient was a 51-year-old man who died last month from acute liver failure.
Two teenage boys, who couldn't walk independently, died earlier this year from liver failure after they received Sarepta's gene therapy Elevidys, approved to treat a rare condition called Duchenne muscular dystrophy.
Sarepta and the Department of Health and Human Services did not immediately respond to a Reuters request for comment outside of their business hours.
The fatalities have brought Sarepta under heightened regulatory scrutiny, and cast doubts on the safety and future demand for Elevidys.
William Blair analyst Sami Corwin said this could amplify patient hesitancy to use Elevidys and increase investor distrust since Sarepta did not disclose the latest fatality on a call earlier this week.
The company said on Wednesday it had halted development of several gene therapies for limb-girdle muscular dystrophy, a group of genetic disorders that primarily weaken the hip and shoulder muscles.
Sarepta had also said it planned to present mid-stage data for its gene therapy, SRP-9003, for the disorder later this year, which will be included in its marketing application to the U.S. Food and Drug Administration.
Corwin added the news of the third patient death could also lead to greater scrutiny over the safety of SRP-9003.
Sarepta plans to cut 500 jobs and add a serious warning on the label of Elevidys for the risk of acute liver injury and liver failure in DMD patients who can walk.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
a few seconds ago
- The Independent
Science proves why your skin wrinkles. Here is what you need to know
Researchers finally know why our skin wrinkles over time - and Silly Putty can help explain it. Scientists at New York's Binghamton University say experimental evidence shows that it's a similar process to stretching out a favorite hoodie or t-shirt from overuse. Essentially, aging skin stretches in one direction, contracts in another, and then collapses. As you age, the contraction gets bigger, resulting in the formation of the skin folds and creases. 'If you stretch Silly Putty, for instance, it stretches horizontally, but it also shrinks in the other direction — it gets thinner,' Associate Professor of Biomedical Engineering, Guy German, explained in a statement. 'That's what skin does, as well.' Wrinkles start to appear after around the age of 25 years old, according to the Cleveland Clinic. Scientists have long believed that skin wrinkles due to genetics, the effects of disease, and damage from the sun. As you get older, your skin cells are replaced at a slower rate, causing the skin's outer layer to thin and forming wrinkles. Lines in the face, including forehead and frown lines, are largely out of our control, as they're caused by repeated muscle movements. Previous studies, using computational models, have also shown changes in the mechanical properties such as the elasticity and structure of the skin's middle layer during aging. The layer, which contains the proteins elastin and collagen, is the home to hair follicles, blood vessels, and sweat glands. Until now, those changes had never been proven experimentally. 'When I got into this field, that was one of my goals – can I figure out aging?' said German. 'Because if I look at the TV, the radio, online, at shops, I'm being told 1,000 different things about how to improve my skin health, and I want to know what's right and what isn't.' To reach these conclusions, German and his team used a low-force tensometer to stretch out seven tiny strips of skin from people between the ages 16 through 91, simulating the forces the skin naturally experiences. The tensometer tests the maximum force a material can withstand while being pulled or stretched before breaking. The skin was collected through elective surgery or tissue from cadavers. They found that the skin has one set of mechanical properties when you're young. As you age, things get a bit 'wonky,' German noted. 'Things degrade a bit, and it turns out the skin stretches laterally more, which causes the actual wrinkles that form,' said German. 'And the reason why that exists in the first place is that your skin is not in a stress-free state. It's actually stretched a little bit. So there are inherent forces within your skin itself, and those are the driving force towards wrinkles.' The research, which didn't delve into how these forces could be halted, was published recently in the Journal of the Mechanical Behavior of Biomedical Materials. Of course, there are other things that we know affect the skin that can contribute to appearance over time. Spending too much time outside can result in a nasty sun burn, as well as age the skin prematurely with the same effect as aging naturally. 'If you spend your life working outside, you're more likely to have more aged and wrinkled skin than those who are office workers, for example,' German warned.
Reuters
a minute ago
- Reuters
South Korea Q2 economic growth fastest in more than a year
SEOUL, July 24 (Reuters) - South Korea's economy grew at the fastest pace in more than a year in the second quarter, beating market expectations, buoyed by rebounding consumer spending and a surge in exports driven by robust demand for technology. Gross domestic product expanded a seasonally adjusted 0.6% in the April-June period from a quarter earlier after contracting 0.2% in the preceding three months, advanced central bank estimates showed on Thursday. It was stronger than the median 0.5% increase forecast in a Reuters poll and the fastest quarterly growth since the first quarter of 2024. South Korea held a snap presidential election on June 3, after the constitutional court in early April upheld former President Yoon Suk Yeol's impeachment over his failed martial law order, ending six months of political uncertainty. By expenditure, private consumption rose 0.5% over the quarter, while construction and facility investments each fell 1.5%, according to the Bank of Korea. Exports jumped 4.2%, led by semiconductors, after falling 0.6% in the previous quarter amid U.S. tariff uncertainty. It was the strongest quarterly performance since the third quarter of 2020. U.S. President Donald Trump's 25% "reciprocal" tariffs against South Korea introduced in early April are currently paused until August 1 for trade negotiations, while some industries like autos and steel have been hit by high product-specific tariffs. On an annual basis, Asia's fourth-largest economy grew 0.5% in the second quarter, compared with no growth in the first quarter and a 0.4% expansion expected by economists.
Reuters
a minute ago
- Reuters
Instant View: Tesla says it started building initial versions of an affordable car, posts a steep sales decline
WASHINGTON, July 23 (Reuters) - Tesla(TSLA.O), opens new tab said on Wednesday it has built initial versions of an affordable car, a move likely meant to stem the steep decline in sales the company has experienced in markets across the world. Elon Musk's electric vehicle maker posted the worst quarterly sales decline in more than a decade and profit that missed Wall Street targets, but its profit margin on making cars was better than many feared. MARKET REACTION: Tesla shares were down nearly 5% in after-hours trading. COMMENTS: JACOB BOURNE, ANALYST, EMARKETER, NEW YORK: "Tesla's disappointing results aren't surprising given the rocky road it's traveled recently. But the company maintains a strong foundation in the key growth sectors of energy storage, robotics, and AI-powered transportation. While traditional automakers like GM are gaining EV market share, we can expect that Tesla will continue pushing the needle on innovation if it can get a better handle on its current leadership distractions. Key challenges that will linger are supply chain risks related to its reliance on China and fierce competition from Chinese EV makers in that market. Tesla doesn't need to choose between cars and future tech. There are technical synergies between EVs, robotaxis, energy systems, and robotics that could accelerate innovation across all fronts. The question is whether leadership can execute on this integrated vision in this fast-moving market." ANDREW ROCCO, STOCK STRATEGIST, ZACKS INVESTMENT RESEARCH, CHICAGO: "Tesla delivered earnings Wednesday night that fell short of top-and-bottom line expectations slightly. Despite the earnings miss, Tesla shares were buoyed early by the fact that the bleeding in gross margins has seemingly come to a halt, with gross margins coming in at 17.2% versus Wall Street estimates of 16.5%. The gross margin beat is especially impressive when investors consider that Tesla has been offering generous incentives and lower prices to its consumers. Coming in to the report, Wall Street expectations were dire amid a slowing core EV business and CEO Elon Musk's reputational damage on both sides of the political aisle. Nevertheless, Tesla has limped over the low bar that was a dramatic earnings miss and delivered earnings that were better than most feared. Additionally, news broke right before the market closed that Tesla is in "early talks" with the state of Nevada to expand its robotaxi service. If Tesla can convince investors that it will scale its robotaxi service rapidly, shareholders will be more forgiving regarding the core EV business, as Musk and his team look to expand into new verticals, transitioning and diversifying the business." THOMAS MONTEIRO, SENIOR ANALYST, "Although still far from what fundamentals would suggest for a trillion-dollar company, Tesla's latest numbers do spark some optimism, indicating that the worst is likely behind it—at least in terms of the core auto business. Given the plethora of headwinds faced during the difficult Q2 - both internally and on the macro front - margin deterioration appears to have come in at the lower end of the curve. When combined with improving cyclical demand dynamics in markets like China and parts of the US, this suggests that full-year results might not be as dire as previously expected following the disastrous first half of the year. This also shows that the company has weathered the tariff storm somewhat better than initially projected, optimizing the production/delivery equation in the US. While it remains unclear how much of a hit regulatory credits will take in Q3, it's evident the company will need to continue refining its production strategy elsewhere to better navigate the second half. From this perspective, recent product announcements are aligned with those strategic needs—particularly around the highly anticipated Model 2. With Tesla entering the Indian market and working to regain ground in China, we view this as a potential game-changer for H2. All things considered—and while we're still a ways off from seeing true fundamental support for the current share price—the outlook for the core business is looking somewhat better. This could continue to support Tesla's long-term transition into a fully AI/robotics-driven company, which appears to be where Musk is placing his bets."
